Observed Signal · Sep 24, 2026 · Product Launch · Source: Tech.eu (European Tech & Deals) · Impact: 3/5 · Sentiment: Positive
Cerebionics Develops Non-Invasive BCI to Translate Intent into Machine Commands
Cerebionics, a Norwegian startup founded by Agnessa Pedersen, is developing a non-invasive brain-computer interface (BCI) platform that uses EEG electrodes to translate human intent into commands for machines. The platform aims to provide an additional control channel for various systems, including drones, unmanned ground vehicles, and C2 APIs. Unlike Neuralink's invasive approach, Cerebionics focuses on higher-level commands rather than fine motor control. The startup has tested its technology with Ukrainian soldiers, receiving feedback to improve robustness. Cerebionics has received commercial interest through letters of intent and is currently scaling its team. The company anticipates applications in defense, healthcare, consumer, and industry, with future potential in gaming and integration into wearables like smart glasses.
Novel BCI platform with potential defense and commercial applications, but early-stage and not directly adtech-related.
Track Real-Time Technology Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Cerebionics is developing a non-invasive BCI platform using EEG to translate intent into commands.
- Founded by Norwegian Agnessa Pedersen, who moved to London and built a team of four.
- The technology has been tested with Ukrainian soldiers; one veteran lost his hand and sought alternative control.
- Cerebionics has received several letters of intent from commercial entities.
- The company focuses on high-level commands such as directional movement and is expanding its command dictionary.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
China's BCI Industry Accelerates Toward Commercial Success
China's brain-computer interface (BCI) industry is moving from research toward commercialization, supported by coordinated policy, funding, clinical capacity and manufacturing strength. A national roadmap released in August 2025 targets technical milestones by 2027 and a complete supply chain by 2030. Provincial medical service pricing and an 11.6 billion yuan brain science fund aim to accelerate insurance reimbursement and commercial adoption, keeping near-term applications concentrated in healthcare. Chinese startups (including NeuroXess, Gestala, BrainCo and others) are advancing both invasive and noninvasive approaches — from implantable flexible electrodes to ultrasound BCIs — and clinical trials have scaled, with over 50 flexible implantable trials completed by mid-2025. Market estimates project growth to about $530 million (3.8 billion yuan) in 2025 and substantial expansion by 2040 as regulations and standards evolve.
Encord trials brain-wave data to train physical AI
Encord is running trials in a San Leandro warehouse to create new training data for robotics by combining egocentric video, arm muscle sensors, leader-follower rigs and brain-wave measurements. The brain-wave headset used in the trial was built by German startup Zander Labs; Encord plans to tag datasets with mental-state signals (error, intent, surprise) to test whether they improve robot model performance. Encord says physical training data is scarce and expensive to produce, driving a business model around manufacturing datasets for manipulation tasks. Company leaders estimate the scale needed to advance physical AI is orders of magnitude larger than current corpora, and Encord is experimenting with dense annotation and multimodal signals to increase dataset value.
Cerebras Set to File for IPO
Cerebras, an AI chipmaker, is expected to file to go public on April 17, 2026, according to two people familiar with the matter. The company has shifted from selling chips to operating them as a cloud service in its own data centers. In January it announced an agreement to provide up to 750 megawatts of compute to OpenAI through 2028 valued at over $10 billion; sources say that relationship has since expanded to over $20 billion and includes warrants for OpenAI to buy Cerebras shares. Oracle has mentioned offering Cerebras chips. Cerebras previously announced IPO plans in 2024 but withdrew paperwork last year to update financial disclosures and strategy. The company raised $1.1 billion in September at an $8.1 billion valuation. Cerebras was founded in 2016 and is based in Sunnyvale, California; Andrew Feldman is co-founder and CEO.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.